MedPath

Comparison of continuous and intermittent infusion administration methods of Vancomyci

Phase 3
Recruiting
Conditions
Proven or suspected Infection with methicillin resistant staphylococcus aureus candidate for Vancomycin Treatment.
Methicillin resistant Staphylococcus aureus infection, unspecified site
A49.02
Registration Number
IRCT20120415009475N12
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria

Age 2 months to 15 years old
Weight under 67 kg
Central venous access
Obtaining written consent from a legal guardian

Exclusion Criteria

Renal impairment, GFR<50 ml/min (Schwartz formula)
Need for hemodialysis or CRRT
Need for extracorporeal membrane oxygenation or plasmapheresis
Loss of Central venous access
Lysis of blood samples
Discontinuation of vancomycin before 3 days of administration due to clinical judgment
Retraction of consent by legal guardian

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath